Asset 2Asset 2Asset 2Asset 2
  • Capabilities
    • Trial Design and Management
    • Data Management
    • Regulatory and Quality
    • Consulting and Program Management
    • Biospecimens and Logistics
  • Expertise
    • Trial Types
    • Health Innovation Solutions
    • Clinical Applications
  • About Us
    • Company
    • Management Team
  • News & Events
  • Contact
✕
            No results See all results
            • Filter by
            • Categories
            • Tags
            • Authors
            • Show all
            • All
            • Events
            • GBC Blog
            • In Vitro Diagnostics - IVD News
            • Press Releases
            • All
            • All
            • neil.mucci@globalbioclinical.com
            September 4, 2018
            Published by admin on September 4, 2018
            Categories
            • In Vitro Diagnostics - IVD News

            Curetis Subsidiary Ares Genetics Initiates Development of AI-Powered Infectious Disease Test

            ARESupa test aims at broad detection of microbial infections employing next-generation sequencing and artificial intelligence Curetis explores venture capital (VC) funding for Ares Genetics while assessing […]
            Do you like it?0
            Read more
            August 9, 2018
            Published by admin on August 9, 2018
            Categories
            • In Vitro Diagnostics - IVD News

            Epigenomics Posts 88 Percent Increase in Q2 Revenues

            Aug 08, 2018  NEW YORK (GenomeWeb) — Epigenomics reported today an 88 percent year-over-year increase in second quarter revenues amid strong growth in product sales and […]
            Do you like it?0
            Read more
            July 2, 2018
            Published by admin on July 2, 2018
            Categories
            • In Vitro Diagnostics - IVD News

            Epigenomics AG: Liquid Biopsy Test for Liver Cancer Detection to Obtain CE Mark

            – Epigenomics plans to CE Mark mSEPT9 blood test for liver cancer by year-end 2018, enabling commercialization in Europe – Prospective U.S. trial for FDA submission […]
            Do you like it?0
            Read more
            April 19, 2018
            Published by admin on April 19, 2018
            Categories
            • In Vitro Diagnostics - IVD News

            Curetis Launches CE-IVD Marked Unyvero Urinary Tract Infection (UTI) Cartridge

            UTI panel covers 103 diagnostic targets 443-patient multi-center study demonstrates overall weighted average sensitivity of 95.6% at an overall weighted average specificity of 99.3%.  Amsterdam, the […]
            Do you like it?0
            Read more
            April 4, 2018
            Published by admin on April 4, 2018
            Categories
            • In Vitro Diagnostics - IVD News

            Curetis Receives U.S. FDA De Novo Clearance of Unyvero System and Unyvero LRT Lower Respiratory Tract Infection Cartridge

            – First ever multiplex MDx test to be granted clearance by the FDA for this indication – Commercial launch in the U.S. expected this quarter Amsterdam, […]
            Do you like it?0
            Read more
            April 4, 2018
            Published by admin on April 4, 2018
            Categories
            • In Vitro Diagnostics - IVD News

            Curetis Unyvero BCU Blood Culture Application Receives Approval from Singapore Health Sciences Authority

            – Second market authorization for Unyvero Cartridges this year in Singapore Amsterdam, the Netherlands, and Holzgerlingen, Germany, April 04, 2018; published at 11:30 am CEST — […]
            Do you like it?0
            Read more
            March 6, 2018
            Published by admin on March 6, 2018
            Categories
            • In Vitro Diagnostics - IVD News

            Curetis Subsidiary Ares Genetics Wins Incubator Stay in Silicon Valley

            – Award winner in “GoSiliconValley” competition by Austrian Economic Chambers – Support for business development in U.S. market Amsterdam, the Netherlands, San Diego, CA, USA, and […]
            Do you like it?0
            Read more
            February 19, 2018
            Published by admin on February 19, 2018
            Categories
            • In Vitro Diagnostics - IVD News

            Curetis Expects Near Term Decision by FDA Approving First Product in US

            16 Feb 2018 – CEO Oliver Schacht from Curetis (EN Amsterdam:CURE) tells Proactive Investors their Unyvero Platform finds killer bugs in hospitals and tells doctors which […]
            Do you like it?0
            Read more
            February 6, 2018
            Published by admin on February 6, 2018
            Categories
            • In Vitro Diagnostics - IVD News

            Curetis Unyvero Hospitalized Pneumonia Application Receives Singapore Health Sciences Authority Approval

            – Market authorization paves way for broader Unyvero commercial roll-out in ASEAN region through partner Acumen Research Laboratories – Near-term clinical validation study of first cartridge-based […]
            Do you like it?0
            Read more
            Prev page
            1234567891011121314
            Next page

            Global BioClinical
            600 1st Avenue, Suite 330 PMB 80042
            Seattle, WA 98104-2246 USA

            Tel: +1 888 659 1221
            Fax: +1 206 299 9895
            Email: info@globalbioclinical.com

            Capabilities

            Trial Design and Management

            Data Management

            Regulatory and Quality

            Consulting and Program Management

            Biospecimens and Logistics

            Expertise

            Trial Types

            Health Innovation Solutions

            Clinical Applications

            About Us

            Company

            Management Team

            News & Events

            Contact

            © 2025 Global BioClinical. All rights reserved. | Privacy Policy

                      No results See all results
                      ✕